Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Behbahani Ali
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-12-10
Sale
2021-12-27
4:41 pm
Metacrine Inc. MTCR Behbahani Ali
10% Owner
497,270 $0.9944 $494,483 2,563,257
(Indirect)
View
2021-10-18
Purchase
2021-10-19
9:11 pm
Trevi Therapeutics Inc. TRVI Behbahani Ali
10% Owner
1,851,852 $0 $0 11,493,554
(Indirect)
View
2021-06-28
Purchase
2021-06-30
9:28 pm
Bright Health Group Inc. BHG Behbahani Ali
10% Owner
1,944,444 $18 $34,999,992 23,983,073
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:01 pm
Monte Rosa Therapeutics Inc. GLUE Behbahani Ali
Director
10% Owner
1,050,000 $19 $19,950,000 7,692,298
(Indirect)
View
2021-03-16
Purchase
2021-03-18
5:11 pm
Marker Therapeutics Inc. MRKR Behbahani Ali
10% Owner
5,714,285 $1.75 $9,999,999 10,714,285
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:09 pm
Regulus Therapeutics Inc. RGLS Behbahani Ali
10% Owner
4,398,602 $0.622 $2,735,930 11,949,017
(Indirect)
View
2020-09-18
Purchase
2020-09-22
5:42 pm
Metacrine Inc. MTCR Behbahani Ali
10% Owner
769,230 $13 $9,999,990 3,060,527
(Indirect)
View
2020-07-24
Purchase
2020-07-28
5:22 pm
GENOCEA BIOSCIENCES Inc GNCA Behbahani Ali
Director
10% Owner
3,151,260 $2.25 $7,090,335 13,528,196
(Indirect)
View
2020-06-30
Purchase
2020-07-01
5:49 pm
Akouos Inc. AKUS Behbahani Ali
10% Owner
588,235 $17 $9,999,995 4,294,207
(Indirect)
View
2020-04-03
Sale
2020-04-13
8:56 pm
Trevi Therapeutics Inc. TRVI Behbahani Ali
10% Owner
564 $2.66 $1,500 5,937,998
(Indirect)
View
2020-02-03
Purchase
2020-02-05
5:55 pm
Black Diamond Therapeutics Inc. BDTX Behbahani Ali
Director
800,000 $19 $15,200,000 3,448,757
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-12-17
Option Award
2021-12-17
4:50 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Behbahani Ali
Director
2,472 $5.31 3,454,116
(Direct)
View
2021-10-26
Conversion
2021-10-28
9:06 pm
N/A
N/A
MINERVA SURGICAL INC UTRS Behbahani Ali
Director
49,215 $0 19,635
(Direct)
View
2021-10-21
Ownership
2021-10-21
8:02 pm
N/A
N/A
MINERVA SURGICAL INC UTRS Behbahani Ali
Director
0 $0 5,181
(Direct)
View
2021-09-17
Option Award
2021-09-23
5:43 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Behbahani Ali
Director
1,326 $9.9 3,451,644
(Direct)
View
2021-07-01
Option Award
2021-07-02
5:01 pm
2022-07-01
2031-07-01
Adaptimmune Therapeutics PLC ADAP Behbahani Ali
Director
474,385 $0 474,385
(Direct)
View
2021-07-01
Option Award
2021-07-02
4:27 pm
2022-07-01
2031-07-01
GENOCEA BIOSCIENCES Inc GNCA Behbahani Ali
Director
10% Owner
15,000 $0 15,000
(Direct)
View
2021-06-29
Option Award
2021-07-01
5:35 pm
N/A
2031-06-28
CVRx Inc. CVRX Behbahani Ali
Director
10,382 $0 10,382
(Direct)
View
2021-06-28
Conversion
2021-06-30
9:28 pm
N/A
N/A
Bright Health Group Inc. BHG Behbahani Ali
10% Owner
93,285,104 $0 23,983,073
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:01 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Behbahani Ali
Director
10% Owner
30,092,935 $0 7,692,298
(Indirect)
View
2021-06-29
Ownership
2021-06-29
9:32 pm
N/A
2023-12-14
CVRx Inc. CVRX Behbahani Ali
Director
0 $0 5,244
(Direct)
View
2021-06-23
Option Award
2021-06-25
5:47 pm
N/A
2031-06-22
Monte Rosa Therapeutics Inc. GLUE Behbahani Ali
Director
10% Owner
47,132 $0 47,132
(Direct)
View
2021-06-24
Ownership
2021-06-24
9:23 pm
N/A
N/A
Bright Health Group Inc. BHG Behbahani Ali
10% Owner
0 $0 69,963,828
(Indirect)
View
2021-06-23
Ownership
2021-06-23
9:03 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Behbahani Ali
Director
10% Owner
0 $0 6,642,298
(Indirect)
View
2021-06-18
Option Award
2021-06-22
7:18 pm
N/A
2031-06-17
Black Diamond Therapeutics Inc. BDTX Behbahani Ali
Director
15,000 $0 3,465,318
(Direct)
View
2021-06-18
Option Award
2021-06-22
7:18 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Behbahani Ali
Director
1,014 $12.95 3,465,318
(Direct)
View
2021-06-13
Option Award
2021-06-15
4:25 pm
N/A
2031-06-12
Nkarta Inc. NKTK Behbahani Ali
Director
16,511 $0 16,511
(Direct)
View
2021-06-10
Option Award
2021-06-14
6:23 pm
N/A
2031-06-10
CRISPR Therapeutics AG CRSP Behbahani Ali
Director
10,000 $0 10,000
(Direct)
View
2021-06-07
Option Award
2021-06-09
8:52 pm
N/A
2031-06-06
Oyster Point Pharma Inc. OYST Behbahani Ali
Director
8,665 $0 15,265
(Direct)
View
2021-03-18
Option Award
2021-03-22
8:33 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Behbahani Ali
Director
547 $24.01 3,449,304
(Direct)
View
2021-03-15
Ownership
2021-03-16
6:29 pm
N/A
N/A
Savara Inc SVRA Behbahani Ali
10% Owner
0 $0 24,137,931
(Indirect)
View
2020-09-18
Conversion
2020-09-22
5:42 pm
N/A
N/A
Metacrine Inc. MTCR Behbahani Ali
10% Owner
2,291,297 $0 3,060,527
(Indirect)
View
2020-09-15
Ownership
2020-09-15
5:25 pm
N/A
N/A
Metacrine Inc. MTCR Behbahani Ali
10% Owner
0 $0 2,291,297
(Indirect)
View
2020-08-13
Other
2020-08-14
4:30 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Behbahani Ali
Director
71 $0 341
(Direct)
View
2020-07-09
Option Award
2020-07-13
9:47 pm
N/A
2030-07-08
Nkarta Inc. NKTK Behbahani Ali
Director
10,700 $0 10,700
(Direct)
View
2020-06-30
Conversion
2020-07-01
5:49 pm
N/A
N/A
Akouos Inc. AKUS Behbahani Ali
10% Owner
3,705,972 $0 4,294,207
(Indirect)
View
2020-07-01
Option Award
2020-07-01
5:13 pm
2021-07-01
2030-07-01
Adaptimmune Therapeutics PLC ADAP Behbahani Ali
Director
184,258 $0 184,258
(Direct)
View
2020-06-25
Ownership
2020-06-25
7:16 pm
N/A
N/A
Akouos Inc. AKUS Behbahani Ali
10% Owner
0 $0 3,705,972
(Indirect)
View
2020-06-18
Option Award
2020-06-19
7:38 pm
2021-06-18
2030-06-18
GENOCEA BIOSCIENCES Inc GNCA Behbahani Ali
Director
10% Owner
15,000 $0 15,000
(Direct)
View
2020-06-11
Option Award
2020-06-15
7:49 pm
N/A
2030-06-11
CRISPR Therapeutics AG CRSP Behbahani Ali
Director
15,000 $0 15,000
(Direct)
View
2020-06-08
Option Award
2020-06-10
9:17 pm
N/A
N/A
Oyster Point Pharma Inc. OYST Behbahani Ali
Director
6,600 $0 6,600
(Direct)
View
2020-04-03
Exercise
2020-04-13
8:56 pm
2019-05-09
2022-05-06
Trevi Therapeutics Inc. TRVI Behbahani Ali
10% Owner
1,500,000 $0 5,937,998
(Indirect)
View
2020-04-03
Exercise
2020-04-13
8:56 pm
N/A
N/A
Trevi Therapeutics Inc. TRVI Behbahani Ali
10% Owner
1,500,000 $0.001 5,937,998
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:55 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Behbahani Ali
Director
10,636,909 $0 3,448,757
(Indirect)
View
2020-01-29
Ownership
2020-01-29
8:11 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Behbahani Ali
Director
10% Owner
0 $0 2,648,757
(Indirect)
View
Goto 0, 1, Next